Mci clinical trials

Explore recruiting mci clinical trials.

Recruiting mci studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mci trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE plus)

Romania, Bulgaria, Belgium, Croatia, France, Greece +15 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE)

Italy, Bulgaria, Romania, Portugal, Hungary, Ireland +15 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multi-Center, Single Arm, Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of GSK4527226 [AL101] in Participants with Early Alzheimer’s Disease.

Sweden, Norway, Italy, France, Spain, Finland +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Parallel Group, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Multicenter Treatment Study to Evaluate the Efficacy and Safety of GSK4527226 [AL101] Intravenous Infusion Compared with Placebo in Patients with Early Alzheimer’s Disease

Germany, Netherlands, Finland, France, Italy, Norway +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia

Finland, Spain, Germany, Sweden, France, Denmark +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomised, double-blind, placebo-controlled study to assess safety and efficacy of PRI-002 in patients with MCI or mild dementia due to Alzheimer’s disease (AD)

France, Netherlands, Spain, Italy, Poland, Germany +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Mci trials by city

Mci in Toronto Mci in Vancouver Mci in Montreal Mci in Calgary Mci in Edmonton Mci in Ottawa Mci in Winnipeg Mci in Quebec City Mci in Hamilton Mci in Kitchener Mci in London Mci in Halifax Mci in New York Mci in Los Angeles Mci in Chicago Mci in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease